Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2023

16-08-2022 | Esophageal Cancer | Original Article

Impact of Medicaid Expansion on Incidence and Mortality from Gastric and Esophageal Cancer

Authors: Elaheh Niroomand, Smriti Rajita Kumar, David Goldberg, Shria Kumar

Published in: Digestive Diseases and Sciences | Issue 4/2023

Login to get access

Abstract

Background and Aims

Individuals in Medicaid expanded states have increased access to treatment for medical conditions and other health care resources. Esophageal and gastric cancer are associated with several modifiable risk factors (e.g. smoking, drinking, Helicobacter pylori infection). The impact of Medicaid expansion on these cancers incidence and mortality remains uninvestigated.

Methods

We evaluated the association between Medicaid expansion and gastric and esophageal cancer incidence and mortality in adults aged 25–64. We employed an observational design using a difference-in-differences method with state level data, from 2010 to 2017. Annual, age-adjusted gastric and esophageal cancer incidence and mortality rates, from the CDC Wonder Database, were analyzed. Rates were adjusted for by several socio-demographic factors.

Results

Expansion and non-expansion states were similar in percent Hispanic ethnicity and female gender. The non-expansion states had significantly higher proportion of Black race, diabetics, obese persons, smokers, and those living below the federal poverty line. Adjusted analyses demonstrate that expansion states had significantly fewer new cases of gastric cancer: − 1.6 (95% CI 0.2–3.5; P = 0.08) per 1,000,000 persons per year. No significant association was seen between Medicaid expansion and gastric cancer mortality (0.46 [95% CI − 0.08 to 0.17; P = 0.46]) and esophageal cancer incidence (0.8 [95% CI − 0.08 to 0.24; P = 0.33]) and mortality (1.0 [95% CI − 0.06 to 0.26; P = 0.21]) in multivariable analyses.

Conclusion

States that adopted Medicaid expansion saw a decrease in gastric cancer incidence when compared to states that did not expand Medicaid. Though several factors may influence gastric cancer incidence, this association is important to consider during health policy negotiations.
Appendix
Available only for authorised users
Literature
2.
go back to reference Moss HA, Wu J, Kaplan SJ, Zafar SY. The affordable care act’s medicaid expansion and impact along the cancer-care continuum: A systematic review. J Natl Cancer Inst. 2020;112:779–791.CrossRefPubMedPubMedCentral Moss HA, Wu J, Kaplan SJ, Zafar SY. The affordable care act’s medicaid expansion and impact along the cancer-care continuum: A systematic review. J Natl Cancer Inst. 2020;112:779–791.CrossRefPubMedPubMedCentral
4.
go back to reference Mazurenko O, Balio CP, Agarwal R, Carroll AE, Menachemi N. The effects of Medicaid expansion under the ACA: A systematic review. Health Affairs 2018;37:944–950.CrossRefPubMed Mazurenko O, Balio CP, Agarwal R, Carroll AE, Menachemi N. The effects of Medicaid expansion under the ACA: A systematic review. Health Affairs 2018;37:944–950.CrossRefPubMed
5.
go back to reference Lam MB, Phelan J, Orav EJ, Jha AK, Keating NL. Medicaid expansion and mortality among patients with breast, lung, and colorectal cancer. JAMA Netw Open. 2020;3:e2024366.CrossRefPubMedPubMedCentral Lam MB, Phelan J, Orav EJ, Jha AK, Keating NL. Medicaid expansion and mortality among patients with breast, lung, and colorectal cancer. JAMA Netw Open. 2020;3:e2024366.CrossRefPubMedPubMedCentral
7.
go back to reference Semprini J, Olopade O. Evaluating the effect of medicaid expansion on black/white breast cancer mortality disparities: A difference-in-difference analysis. Am Soc Clin Oncol. 2020;6:1178–1183. Semprini J, Olopade O. Evaluating the effect of medicaid expansion on black/white breast cancer mortality disparities: A difference-in-difference analysis. Am Soc Clin Oncol. 2020;6:1178–1183.
8.
go back to reference Albright BB, Chino F, Chino JP, Havrilesky LJ, Aviki EM, Moss HA. Association of Medicaid expansion with mortality from gynecologic cancers. Am J Obstet Gynecol. 2021;224:323–325.CrossRefPubMed Albright BB, Chino F, Chino JP, Havrilesky LJ, Aviki EM, Moss HA. Association of Medicaid expansion with mortality from gynecologic cancers. Am J Obstet Gynecol. 2021;224:323–325.CrossRefPubMed
9.
go back to reference Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg. 2018;41:210–215.CrossRefPubMed Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg. 2018;41:210–215.CrossRefPubMed
10.
go back to reference Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M, Kavosi Z. Risk factors for gastric cancer: A systematic review. Asian Pac J Cancer Prev. 2018;19:591–603.PubMedPubMedCentral Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M, Kavosi Z. Risk factors for gastric cancer: A systematic review. Asian Pac J Cancer Prev. 2018;19:591–603.PubMedPubMedCentral
11.
go back to reference Swaminathan S, Sommers BD, Thorsness R, Mehrotra R, Lee Y, Trivedi AN. Association of Medicaid expansion with 1-year mortality among patients with end-stage renal disease. JAMA. 2018;320:2242–2250.CrossRefPubMedPubMedCentral Swaminathan S, Sommers BD, Thorsness R, Mehrotra R, Lee Y, Trivedi AN. Association of Medicaid expansion with 1-year mortality among patients with end-stage renal disease. JAMA. 2018;320:2242–2250.CrossRefPubMedPubMedCentral
13.
go back to reference Dimick JB, Ryan AM. Methods for evaluating changes in health care policy: The difference-in-differences approach. JAMA. 2014;312:2401–2402.CrossRefPubMed Dimick JB, Ryan AM. Methods for evaluating changes in health care policy: The difference-in-differences approach. JAMA. 2014;312:2401–2402.CrossRefPubMed
15.
go back to reference Simkin J, Nash SH, Barchuk A et al. Stomach cancer incidence and mortality trends among circumpolar nations. Cancer Epidemiol Biomarkers Prev. 2021;30:845–856.CrossRefPubMed Simkin J, Nash SH, Barchuk A et al. Stomach cancer incidence and mortality trends among circumpolar nations. Cancer Epidemiol Biomarkers Prev. 2021;30:845–856.CrossRefPubMed
17.
19.
go back to reference Pourhoseingholi MA, Fazeli Z, Moghimi-Dehkordi B et al. Increased oesophageal cancer mortality rate in Iran. Arab J Gastroenterol. 2012;13:82–84.CrossRefPubMed Pourhoseingholi MA, Fazeli Z, Moghimi-Dehkordi B et al. Increased oesophageal cancer mortality rate in Iran. Arab J Gastroenterol. 2012;13:82–84.CrossRefPubMed
21.
go back to reference Schonnemann KR, Mortensen MB, Krogh M et al. Trends in upper gastro-intestinal cancer among the elderly in Denmark, 1980–2012. Acta Oncol. 2016;55:23–28.CrossRefPubMed Schonnemann KR, Mortensen MB, Krogh M et al. Trends in upper gastro-intestinal cancer among the elderly in Denmark, 1980–2012. Acta Oncol. 2016;55:23–28.CrossRefPubMed
22.
go back to reference Patwardhan V, Paul S, Corey KE et al. Hepatocellular carcinoma screening rates vary by etiology of cirrhosis and involvement of gastrointestinal sub-specialists. Dig Dis Sci 2011;56:3316–3322.CrossRefPubMedPubMedCentral Patwardhan V, Paul S, Corey KE et al. Hepatocellular carcinoma screening rates vary by etiology of cirrhosis and involvement of gastrointestinal sub-specialists. Dig Dis Sci 2011;56:3316–3322.CrossRefPubMedPubMedCentral
23.
go back to reference Goldberg DS, French B, Forde KA et al. Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans. JAMA. 2014;311:1234–1243.CrossRefPubMedPubMedCentral Goldberg DS, French B, Forde KA et al. Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans. JAMA. 2014;311:1234–1243.CrossRefPubMedPubMedCentral
30.
go back to reference Bilinski A, Hatfield LA. Nothing to see here? Non-inferiority approaches to parallel trends and other model assumptions. statME. 2019. arXiv:1805.03273 Bilinski A, Hatfield LA. Nothing to see here? Non-inferiority approaches to parallel trends and other model assumptions. statME. 2019. arXiv:1805.03273
31.
go back to reference El-Serag HB, Kao JY, Kanwal F, et al. Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol. 2018;16(7):992–1002 e1006. El-Serag HB, Kao JY, Kanwal F, et al. Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol. 2018;16(7):992–1002 e1006.
32.
go back to reference Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS. Risk factors and incidence of gastric cancer after detection of helicobacter pylori infection: A large cohort study. Gastroenterology. 2020;158(3):527–536 e527. Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS. Risk factors and incidence of gastric cancer after detection of helicobacter pylori infection: A large cohort study. Gastroenterology. 2020;158(3):527–536 e527.
33.
go back to reference Li WQ, Zhang JY, Ma JL et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: Follow-up of a randomized intervention trial. BMJ. 2019;366:l5016.CrossRefPubMedPubMedCentral Li WQ, Zhang JY, Ma JL et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: Follow-up of a randomized intervention trial. BMJ. 2019;366:l5016.CrossRefPubMedPubMedCentral
34.
go back to reference Sommers BD, Blendon RJ, Orav EJ, Epstein AM. Changes in utilization and health among low-income adults after Medicaid expansion or expanded private insurance. JAMA Intern Med. 2016;176:1501–1509.CrossRefPubMed Sommers BD, Blendon RJ, Orav EJ, Epstein AM. Changes in utilization and health among low-income adults after Medicaid expansion or expanded private insurance. JAMA Intern Med. 2016;176:1501–1509.CrossRefPubMed
35.
go back to reference Heckman CJ, Egleston BL, Hofmann MT. Efficacy of motivational interviewing for smoking cessation: A systematic review and meta-analysis. Tob Control. 2010;19:410–416.CrossRefPubMed Heckman CJ, Egleston BL, Hofmann MT. Efficacy of motivational interviewing for smoking cessation: A systematic review and meta-analysis. Tob Control. 2010;19:410–416.CrossRefPubMed
36.
go back to reference Armstrong MJ, Mottershead TA, Ronksley PE, Sigal RJ, Campbell TS, Hemmelgarn BR. Motivational interviewing to improve weight loss in overweight and/or obese patients: A systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2011;12:709–723.PubMed Armstrong MJ, Mottershead TA, Ronksley PE, Sigal RJ, Campbell TS, Hemmelgarn BR. Motivational interviewing to improve weight loss in overweight and/or obese patients: A systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2011;12:709–723.PubMed
39.
go back to reference Hewgley WP, Ju M, Porembka M. Impact of Medicaid Expansion on Chemotherapy Utilization in Metastatic Gastric Cancer Patients. Academic Surgical Congress Abstract Archives. 2020. Hewgley WP, Ju M, Porembka M. Impact of Medicaid Expansion on Chemotherapy Utilization in Metastatic Gastric Cancer Patients. Academic Surgical Congress Abstract Archives. 2020.
40.
go back to reference Howard J. Minimum Latency & Types or Categories of Cancer. cdc.gov2014. Howard J. Minimum Latency & Types or Categories of Cancer. cdc.gov2014.
41.
go back to reference den Hoed CM, van Blankenstein M, Dees J, Kuipers EJ. The minimal incubation period from the onset of Barrett’s oesophagus to symptomatic adenocarcinoma. Br J Cancer. 2011;105:200–205.CrossRef den Hoed CM, van Blankenstein M, Dees J, Kuipers EJ. The minimal incubation period from the onset of Barrett’s oesophagus to symptomatic adenocarcinoma. Br J Cancer. 2011;105:200–205.CrossRef
42.
go back to reference Soni A. The effects of public health insurance on health behaviors: Evidence from the fifth year of Medicaid expansion. Health Econ. 2020;29:1586–1605.CrossRefPubMed Soni A. The effects of public health insurance on health behaviors: Evidence from the fifth year of Medicaid expansion. Health Econ. 2020;29:1586–1605.CrossRefPubMed
44.
go back to reference Leung WK, Lin SR, Ching JY et al. Factors predicting progression of gastric intestinal metaplasia: Results of a randomised trial on Helicobacter pylori eradication. Gut. 2004;53:1244–1249.CrossRefPubMedPubMedCentral Leung WK, Lin SR, Ching JY et al. Factors predicting progression of gastric intestinal metaplasia: Results of a randomised trial on Helicobacter pylori eradication. Gut. 2004;53:1244–1249.CrossRefPubMedPubMedCentral
45.
go back to reference Correa P, Fontham ETH, Bravo JC et al. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst. 2000;92:1881–1888.CrossRefPubMed Correa P, Fontham ETH, Bravo JC et al. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst. 2000;92:1881–1888.CrossRefPubMed
46.
go back to reference Wong BCY, Zhang L, Ma J-L et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut. 2012;61:812–818.CrossRefPubMed Wong BCY, Zhang L, Ma J-L et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut. 2012;61:812–818.CrossRefPubMed
47.
go back to reference Song S, Kucik JE. Trends in the impact of Medicaid expansion on clinical preventative services. Am J Prev Med. 2021;62:752–762.CrossRefPubMed Song S, Kucik JE. Trends in the impact of Medicaid expansion on clinical preventative services. Am J Prev Med. 2021;62:752–762.CrossRefPubMed
48.
go back to reference Diehl TM, Abbott DE. Association of Medicaid expansion with diagnosis and management of colon cancer. J Am Coll Surg. 2021;232:156–158.CrossRefPubMed Diehl TM, Abbott DE. Association of Medicaid expansion with diagnosis and management of colon cancer. J Am Coll Surg. 2021;232:156–158.CrossRefPubMed
49.
go back to reference Committee ASoP, Evans JA, Early DS, et al. The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76(6):1087–1094. Committee ASoP, Evans JA, Early DS, et al. The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76(6):1087–1094.
50.
go back to reference Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointest Endosc. 2016;84:18–28.CrossRefPubMed Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointest Endosc. 2016;84:18–28.CrossRefPubMed
51.
go back to reference Zavala VA, Bracci PM, Carethers JM et al. Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer. 2021;124:315–332.CrossRefPubMed Zavala VA, Bracci PM, Carethers JM et al. Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer. 2021;124:315–332.CrossRefPubMed
52.
go back to reference Shaheen NJ, Falk GW, Iyer PG et al. Diagnosis and management of Barrett’s esophagus: An updated ACG guideline. Am J Gastroenterol. 2022;117:559–587.CrossRefPubMed Shaheen NJ, Falk GW, Iyer PG et al. Diagnosis and management of Barrett’s esophagus: An updated ACG guideline. Am J Gastroenterol. 2022;117:559–587.CrossRefPubMed
Metadata
Title
Impact of Medicaid Expansion on Incidence and Mortality from Gastric and Esophageal Cancer
Authors
Elaheh Niroomand
Smriti Rajita Kumar
David Goldberg
Shria Kumar
Publication date
16-08-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07659-6

Other articles of this Issue 4/2023

Digestive Diseases and Sciences 4/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.